<div id="readability-page-1"><p>Martin Currie Ltd. cut its holdings in shares of  Xylem Inc. (NYSE:XYL - Free Report) by 73.8% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,395 shares of the industrial products company's stock after selling 6,732 shares during the period. Martin Currie Ltd.'s holdings in Xylem were worth $310,000 as of its most recent filing with the Securities and Exchange Commission (SEC).</p><ul><li>3 Sustainable Stocks Benefiting From the AI Energy Surge</li></ul><p>Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Maseco LLP purchased a new stake in shares of  Xylem in the second quarter worth about $31,000.  ST Germain D J Co. Inc. lifted its holdings in  Xylem by 950.0% in the second quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company's stock valued at $33,000 after acquiring an additional 228 shares during the period.  Headlands Technologies LLC boosted its position in  Xylem by 90.6% in the 1st quarter. Headlands Technologies LLC now owns 305 shares of the industrial products company's stock worth $36,000 after purchasing an additional 145 shares in the last quarter.  Signature Resources Capital Management LLC acquired a new stake in shares of  Xylem during the 2nd quarter worth approximately $39,000.  Finally, Zions Bancorporation National Association UT purchased a new position in shares of  Xylem during the 1st quarter valued at approximately $40,000. 87.96% of the stock is owned by institutional investors and hedge funds. </p><h2>Xylem Trading Down 0.6%</h2><p>XYL opened at $138.08 on Friday. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.96 and a quick ratio of 1.43. The company's 50 day simple moving average is $146.19 and its two-hundred day simple moving average is $137.30. The firm has a market capitalization of $33.62 billion, a price-to-earnings ratio of 35.50, a price-to-earnings-growth ratio of 2.50 and a beta of 1.15. Xylem Inc. has a 1-year low of $100.47 and a 1-year high of $154.27. </p><ul><li>Investing in Sustainable Solutions: 2 Top Water Tech Stocks</li></ul><p>Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.23 by $0.14. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The firm had revenue of $2.27 billion during the quarter, compared to analysts' expectations of $2.22 billion. During the same period last year, the business earned $1.11 earnings per share. Xylem's revenue was up 7.8% compared to the same quarter last year.  Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. Analysts expect that  Xylem Inc. will post 4.65 EPS for the current fiscal year. </p><h2>Xylem Dividend Announcement</h2><p>The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 23rd. Stockholders of record on Tuesday, November 25th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 1.2%. The ex-dividend date is Tuesday, November 25th. Xylem's dividend payout ratio (DPR) is presently 41.13%. </p><h2>Insider Transactions at Xylem</h2><p>In other news, EVP Claudia S. Toussaint sold 10,421 shares of the company's stock in a transaction dated Thursday, October 30th. The stock was sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the completion of the transaction, the executive vice president directly owned 31,250 shares of the company's stock, valued at approximately $4,770,000. This represents a 25.01% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Victoria D. Harker sold 1,700 shares of the firm's stock in a transaction on Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total transaction of $251,838.00. Following the transaction, the director directly owned 16,875 shares in the company, valued at $2,499,862.50. The trade was a 9.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 13,121 shares of company stock valued at $1,982,459. 0.27% of the stock is currently owned by corporate insiders. </p><h2>Analysts Set New Price Targets</h2><p>A number of analysts recently issued reports on XYL shares. Zacks Research downgraded shares of Xylem from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a report on Tuesday. Citigroup upped their price objective on shares of Xylem from $173.00 to $182.00 and gave the stock a &#34;buy&#34; rating in a research report on Wednesday, October 29th. Barclays raised their target price on Xylem from $165.00 to $172.00 and gave the company an &#34;overweight&#34; rating in a research report on Wednesday, October 29th. Wall Street Zen raised Xylem from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Saturday, August 9th. Finally, Robert W. Baird  set a $178.00 price objective on Xylem in a research report on Wednesday, October 29th. Eight analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $166.90.</p><p><b>Get Our Latest Stock Report on Xylem</b></p><h2>Xylem Profile</h2> (Free Report)<p>Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement &amp; Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.</p><h2>See Also</h2><ul><li>Five stocks we like better than Xylem</li><li>Transportation Stocks Investing</li><li>Datavault AI Just Raised Guidance by 400%—Are You Paying Attention?</li><li>Uptrend Stocks Explained: Learn How to Trade Using Uptrends</li><li>Peter Thiel Dumps NVIDIA and Slashes Tesla Stake—Is the AI Bubble About to Pop?</li><li>What is a Bond Market Holiday? How to Invest and Trade</li><li>Why Lithium Americas Could Be a 2030 Power Play—Not a 2025 One</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVhZTA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVhZTA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Xylem Right Now?</h2><p>Before you consider Xylem, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.</p><p>While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Martin Currie Ltd. reduced its holdings in Xylem Inc. by 73.8% in Q2, now owning 2,395 shares worth $310,000. Other institutional investors also adjusted their stakes. Xylem's stock opened at $138.08 with a market cap of $33.62 billion. The company reported Q3 earnings of $1.37 per share, beating estimates. Xylem announced a quarterly dividend of $0.40 per share. Insiders sold 13,121 shares recently. Analysts have updated their price targets for Xylem.</p>

Martin Currie Ltd. Trims Stock Position in Xylem Inc. $XYL